Home › NDC Lookup › Labelers › Novartis Pharma Stein Ag

Novartis Pharma Stein Ag NDCs and Package Codes

This page lists NDC package records associated with labeler code 17088 (Novartis Pharma Stein Ag) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

39
Package NDCs
39
Products
39
Active listings
0
Discontinued
14
Ingredients
0
Therapeutic classes
8
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
everolimus 11
alpelisib 6
omalizumab 4
asciminib 3
siponimod 3
nilotinib 3
trametinib 2
letrozole 1
dabrafenib 1
Fingolimod hcl 1
By dosage form
TABLET 14
TABLET, FILM COATED 9
INJECTION, SOLUTION 5
TABLET, FOR SUSPENSION 4
CAPSULE 4
INJECTION 1
INJECTION, POWDER, FOR SOLUTION 1
INJECTION, SOLUTION, CONCENTRATE 1

Browse records — 39 products

Drug / product Billing NDC NADAC / unit Status
alpelisib 50 mg/1 TABLET Novartis · NDC 17088-0170-01 · 25000 TABLET in 1 DRUM (17088-0170-1) 17088-0170-01 — On market View →
alpelisib 50 mg/1 TABLET Novartis · NDC 17088-0198-01 · 25000 TABLET in 1 DRUM (17088-0198-1) 17088-0198-01 — On market View →
alpelisib 150 mg/1 TABLET Novartis · NDC 17088-0254-01 · 25000 TABLET in 1 DRUM (17088-0254-1) 17088-0254-01 — On market View →
alpelisib 125 mg/1 TABLET Novartis · NDC 17088-0205-01 · 25000 TABLET in 1 DRUM (17088-0205-1) 17088-0205-01 — On market View →
alpelisib 200 mg/1 TABLET Novartis · NDC 17088-0322-01 · 20000 TABLET in 1 DRUM (17088-0322-1) 17088-0322-01 — On market View →
alpelisib 200 mg/1 TABLET Novartis · NDC 17088-0346-01 · 20000 TABLET in 1 DRUM (17088-0346-1) 17088-0346-01 — On market View →
asciminib 40 mg/1 TABLET, FILM COATED Novartis · NDC 17088-0163-01 · 25000 TABLET, FILM COATED in 1 DRUM (17088-0163-1) 17088-0163-01 — On market View →
asciminib 20 mg/1 TABLET, FILM COATED Novartis · NDC 17088-0156-01 · 25000 TABLET, FILM COATED in 1 DRUM (17088-0156-1) 17088-0156-01 — On market View →
asciminib 100 mg/1 TABLET, FILM COATED Novartis · NDC 17088-0330-01 · 17475 TABLET, FILM COATED in 1 DRUM (17088-0330-1) 17088-0330-01 — On market View →
basiliximab 10 mg/2.5mL INJECTION, POWDER, FOR SOLUTION Novartis · NDC 17088-0370-01 · 2.5 mL in 1 VIAL, SINGLE-USE (17088-0370-1) 17088-0370-01 — On market View →
canakinumab 150 mg/mL INJECTION, SOLUTION Novartis · NDC 17088-0354-01 · 1 mL in 1 VIAL, SINGLE-USE (17088-0354-1) 17088-0354-01 — On market View →
cyclosporine 50 mg/mL INJECTION Novartis · NDC 17088-0362-01 · 5 mL in 1 AMPULE (17088-0362-1) 17088-0362-01 — On market View →
dabrafenib 10 mg/1 TABLET, FOR SUSPENSION Novartis · NDC 17088-0212-01 · 25000 TABLET, FOR SUSPENSION in 1 DRUM (17088-0212-1) 17088-0212-01 — On market View →
everolimus 1 mg/1 TABLET Novartis · NDC 17088-0149-01 · 25000 TABLET in 1 DRUM (17088-0149-1) 17088-0149-01 — On market View →
everolimus 5 mg/1 TABLET Novartis · NDC 17088-0298-01 · 20000 TABLET in 1 DRUM (17088-0298-1) 17088-0298-01 — On market View →
everolimus 5 mg/1 TABLET, FOR SUSPENSION Novartis · NDC 17088-0114-01 · 25000 TABLET, FOR SUSPENSION in 1 DRUM (17088-0114-1) 17088-0114-01 — On market View →
everolimus .25 mg/1 TABLET Novartis · NDC 17088-0314-01 · 62500 TABLET in 1 DRUM (17088-0314-1) 17088-0314-01 — On market View →
everolimus 3 mg/1 TABLET, FOR SUSPENSION Novartis · NDC 17088-0107-01 · 25000 TABLET, FOR SUSPENSION in 1 DRUM (17088-0107-1) 17088-0107-01 — On market View →
everolimus 2 mg/1 TABLET, FOR SUSPENSION Novartis · NDC 17088-0247-01 · 25000 TABLET, FOR SUSPENSION in 1 DRUM (17088-0247-1) 17088-0247-01 — On market View →
everolimus 2.5 mg/1 TABLET Novartis · NDC 17088-0290-01 · 40000 TABLET in 1 DRUM (17088-0290-1) 17088-0290-01 — On market View →
everolimus 7.5 mg/1 TABLET Novartis · NDC 17088-0261-01 · 25000 TABLET in 1 DRUM (17088-0261-1) 17088-0261-01 — On market View →
everolimus 10 mg/1 TABLET Novartis · NDC 17088-0306-01 · 10000 TABLET in 1 DRUM (17088-0306-1) 17088-0306-01 — On market View →
everolimus .75 mg/1 TABLET Novartis · NDC 17088-0142-01 · 25000 TABLET in 1 DRUM (17088-0142-1) 17088-0142-01 — On market View →
everolimus .5 mg/1 TABLET Novartis · NDC 17088-0135-01 · 25000 TABLET in 1 DRUM (17088-0135-1) 17088-0135-01 — On market View →
Fingolimod hcl .5 mg/1 CAPSULE Novartis · NDC 17088-0219-01 · 25000 CAPSULE in 1 DRUM (17088-0219-1) 17088-0219-01 — On market View →
letrozole 2.5 mg/1 TABLET, FILM COATED Novartis · NDC 17088-0100-01 · 25000 TABLET, FILM COATED in 1 DRUM (17088-0100-1) 17088-0100-01 — On market View →
nilotinib 50 mg/1 CAPSULE Novartis · NDC 17088-0240-01 · 25000 CAPSULE in 1 DRUM (17088-0240-1) 17088-0240-01 — On market View →
nilotinib 150 mg/1 CAPSULE Novartis · NDC 17088-0226-01 · 25000 CAPSULE in 1 DRUM (17088-0226-1) 17088-0226-01 — On market View →
nilotinib 200 mg/1 CAPSULE Novartis · NDC 17088-0233-01 · 25000 CAPSULE in 1 DRUM (17088-0233-1) 17088-0233-01 — On market View →
omalizumab 75 mg/.5mL INJECTION, SOLUTION Novartis · NDC 17088-0268-01 · .5 mL in 1 SYRINGE, GLASS (17088-0268-1) 17088-0268-01 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.